Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02208362
What this trial is testing

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Recurrent GlioblastomaRecurrent Malignant GliomaRecurrent WHO Grade II Glioma+5 more
City of Hope Medical Center 65
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00910650
What this trial is testing

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 14
Not applicableEnded earlyNCT05456997
What this trial is testing

Metabolic Myopathy in Endocrinopathy

Who this might be right for
Cushing SyndromePheochromocytomaConns Syndrome+1 more
Barts & The London NHS Trust 1
Testing effectiveness (Phase 2)Study completedNCT00025623
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
European Infant Neuroblastoma Study Group - 1999
Early research (Phase 1)UnknownNCT02149459
What this trial is testing

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy

Who this might be right for
Brain Neoplasms
Sheba Medical Center 18
Not applicableStudy completedNCT03471546
What this trial is testing

Early Palliative Care Intervention in Malignant Glioma

Who this might be right for
Malignant Glioma
Duke University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06264388
What this trial is testing

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Who this might be right for
High Grade GliomaAnaplastic Astrocytoma
Ashish Shah 33
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT03561870
What this trial is testing

Olaparib in Recurrent IDH-mutant Glioma

Who this might be right for
Recurrent IDHMutant High Grade Glioma
Hospices Civils de Lyon 35
Not applicableLooking for participantsNCT07112170
What this trial is testing

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto 52
Testing effectiveness (Phase 2)Study completedNCT00516295
What this trial is testing

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Who this might be right for
Ewing Sarcoma of BoneExtraosseous Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor+1 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Not applicableStudy completedNCT05246319
What this trial is testing

Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsSmall Intestinal NETLymph Node Metastasis
Laurent BRUNAUD 50
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Large-scale testing (Phase 3)Looking for participantsNCT05502900
What this trial is testing

Adjuvant Melatonin for Uveal Melanoma

Who this might be right for
Uveal MelanomaUveal Melanoma, Posterior, Medium/Large SizeEye Cancer, Intraocular Melanoma
Gustav Stalhammar 100
Not applicableStudy completedNCT04719806
What this trial is testing

MR Textural Analysis in Low Grade Gliomas

Who this might be right for
Glioma
Centre Hospitalier Universitaire de Nice 80
Testing effectiveness (Phase 2)Ended earlyNCT00456612
What this trial is testing

Radiosurgery for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beth Israel Deaconess Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01266967
What this trial is testing

GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

Who this might be right for
Melanoma and Brain Metastases
GlaxoSmithKline 172
Testing effectiveness (Phase 2)Study completedNCT00984464
What this trial is testing

Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Oncolytics Biotech 14
Next Page